NEW ORLEANS, Feb. 1, 2012 (GLOBE NEWSWIRE) -- An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association’s International Stroke Conference 2012.
